Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ware

Showing results (681-690 of 721) with videos related to

Pageof 73
Sort By:
Circulation. Genomic and Precision Medicine|April 21, 2025
Clinical Validity of Autosomal Dominant <i>ALPK3</i> Loss-of-Function Variants as a Cause of Hypertrophic CardiomyopathySophie Hespe, Emma S Singer, Chloe Reuter, et al.
Circulation|June 22, 2026
Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry AnalysisRobert Przybylski, Gabrielle Norrish, Brian Claggett, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
Nature Medicine|May 29, 2020
The effect of LRRK2 loss-of-function variants in humansNicola Whiffin, Irina M Armean, Aaron Kleinman, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Journal of the American College of Cardiology|July 30, 2025
Sex Differences in the Genetic Causes of Dilated CardiomyopathyMassimo Mangino, Kathryn A McGurk, Pantazis Theotokis, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
Pageof 73

Showing results (681-690 of 721) with videos related to

Sort By:
Pageof 73
Circulation. Genomic and Precision Medicine|April 21, 2025
Clinical Validity of Autosomal Dominant <i>ALPK3</i> Loss-of-Function Variants as a Cause of Hypertrophic CardiomyopathySophie Hespe, Emma S Singer, Chloe Reuter, et al.
Circulation|June 22, 2026
Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry AnalysisRobert Przybylski, Gabrielle Norrish, Brian Claggett, et al.
Circulation|September 26, 2022
Genetic Architecture of Acute Myocarditis and the Overlap With Inherited CardiomyopathyAmrit S Lota, Mark R Hazebroek, Pantazis Theotokis, et al.
Nature Medicine|May 29, 2020
The effect of LRRK2 loss-of-function variants in humansNicola Whiffin, Irina M Armean, Aaron Kleinman, et al.
Science (New York, N.Y.)|January 20, 2016
De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomaliesJason Homsy, Samir Zaidi, Yufeng Shen, et al.
Nature Genetics|November 22, 2016
Titin-truncating variants affect heart function in disease cohorts and the general populationSebastian Schafer, Antonio de Marvao, Eleonora Adami, et al.
Journal of the American College of Cardiology|July 30, 2025
Sex Differences in the Genetic Causes of Dilated CardiomyopathyMassimo Mangino, Kathryn A McGurk, Pantazis Theotokis, et al.
JACC. Advances|June 28, 2024
Long-Term Arrhythmic Follow-Up and Risk Stratification of Patients With Desmoplakin-Associated Arrhythmogenic Right Ventricular CardiomyopathyAlessio Gasperetti, Richard Carrick, Alexandros Protonotarios, et al.
Journal of the American College of Cardiology|May 20, 2026
Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe RegistrySophie L V M Stroeks, Nicole K Bart, Joseph Rossano, et al.
Nature Genetics|February 18, 2025
Evaluation of polygenic scores for hypertrophic cardiomyopathy in the general population and across clinical settingsSean L Zheng, Sean J Jurgens, Kathryn A McGurk, et al.
Pageof 73